Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Isolated chemotactic factor from patients with endometriosis

Isolated chemotactic factor from patients with endometriosis

US Patent 5877284 · Granted Mar 2, 1999

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of treating osteoporosis comprising administration of PTHrP analog2023
Therapeutic regimens2017
Treatment of vasomotor symptoms with selective estrogen receptor modulators2015
Method of drug delivery for bone anabolic protein2014
Stable composition comprising a PTHrP analogue2012
Method of treating osteoporosis comprising administration of PTHrP analog2010
Substituted benzoxazoles as estrogenic agents2009
Antibody specific for an isolated chemotactic factor from patients with endometr1999